News and Trends 11 Jul 2025 XOMA Royalty’s acquisition of Turnstone Biologics: what do royalty deals offer the biopharma industry? Turnstone Biologics is being acquired by royalty aggregator Xoma Royalty. Discover how royalty deals are shaping the biopharma industry. July 11, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Podcast 11 Jul 2025How OMass Therapeutics is tackling congenital adrenal hyperplasia, a rare genetic disorder This week we talk about Congenital Adrenal Hyperplasia and how OMass Therapeutics is approaching it with the company CEO, Ros Deegan. July 11, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
News and Trends 10 Jul 2025 Radiopharma’s new wave: Nuclidium and Actithera raise the stakes Take a closer look at the radiopharma new wave as Nuclidium and Actithera raise big to develop their platforms. July 10, 2025 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 9 Jul 2025 New hope for CIPN: Can emerging therapies ease chemotherapy’s nerve damage? Delve into the growing field of CIPN, the most common side effect of chemotherapy, as we are getting closer to a first approval. July 9, 2025 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 8 Jul 2025 The biggest biotech funding rounds in June 2025 The companies Insmed, Cidara Therapeutics, and Cogent Biosciences bagged the biggest biotech funding rounds overall in June 2025. July 8, 2025 - 4 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 7 Jul 2025 Biotech in Vienna: a budding life science hub As biotech in Vienna raked in €22.7 billion in 2023, there has been a significant increase in innovation, research, and employment in recent years. July 7, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 4 Jul 2025 14 biotech companies to know in the Boston area in 2025 Explore Boston’s vibrant biotech landscape with fourteen innovative companies leading the charge in life sciences research. July 4, 2025 - 15 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Podcast 4 Jul 2025Persica Pharmaceuticals is treating the cause of chronic lower back pain, not just the symptoms Our guest today, Steve Ruston of Persica Pharmaceuticals is developping a treatment targeting the cause of chronic lower back pain: the bacterial infection. July 4, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
In Depth 3 Jul 2025 Revolutionizing glioblastoma treatment: How CAR-T cell therapy could represent a cure for this deadly brain cancer Find out how CAR-T cell therapy, which has been so groundbreaking in treating blood cancers, could potentially cure glioblastoma. July 3, 2025 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 2 Jul 2025 Top biotech deals in June 2025 Learn about June 2025’s top biotech deals, featuring major collaborations in small molecules, protein therapeutics, and immunotherapies. July 2, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Reports 2 Jul 2025Artificial intelligence and the future of antibody discovery Discover how AI and ML are already shaping therapeutic antibody discovery and explore their future potential. July 2, 2025 Share WhatsApp Twitter Linkedin Email
In Depth 1 Jul 2025 Is an HIV cure possible? The future of HIV therapy Delve into the field of HIV treatment development. Since the virus was discovered, treatments have improved, but are we close to a cure? July 1, 2025 - 11 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email